Molecular genetics of the NCLs - status and perspectives

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 10, 2006, Pages 857-864

  Siintola, Eija ^a   Lehesjoki, Anna Elina ^a   Mole, Sara E ^b  

^a BIOMEDICUM HELSINKI   (Finland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Batten; CLN; Gene; Mutation; NCL; Neuronal ceroid lipofuscinosis

Indexed keywords

CLN1 PROTEIN; CLN2 PROTEIN; CLN3 PROTEIN; CLN4 PROTEIN; CLN5 PROTEIN; CLN6 PROTEIN; CLN7 PROTEIN; CLN8 PROTEIN; CLN9 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 16; CHROMOSOME 1P; CHROMOSOME 8; CLINICAL FEATURE; DEGENERATIVE DISEASE; GENE; GENE MUTATION; HUMAN; MOLECULAR GENETICS; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; SEIZURE; VISUAL IMPAIRMENT;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; MUTATION; NEURONAL CEROID-LIPOFUSCINOSES;

ANIMALIA;

EID: 33750984767     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.05.006     Document Type: Review

References (97)

1. Santavuori P. Neuronal ceroid-lipofuscinoses in childhood. Brain Dev. 10 (1988) 80-83
2. Haltia M. The neuronal ceroid-lipofuscinoses. J. Neuropathol. Exp. Neurol. 62 (2003) 1-13
3. Rider J.A., and Rider D.L. Batten disease: past, present, and future. Am. J. Med. Genet., Suppl. 5 (1988) 21-26
4. Stengel C. Beretning om et maerkeligt sygdomstilfoelde hos fire sodskende i naerheden af Roraas. Eyr. et. medicinsk. Tidskrift. 1 (1826) 347-352
5. Batten F.E. Cerebral degeneration with symmetrical changes in the maculae in two members of a family. Trans. Ophthalmol. Soc. U. K. 23 (1903) 386-390
6. Bielschowsky M. Über spätinfantile familiäre amaurotische idiotie mit kleinhirnsymptonen. Dtsch. Z. Nervenheilkd. 50 (1913) 7-29
7. Batten F.E. Family cerebral degeneration with macular change (so-called juvenile form of family amaurotic idiocy). Q. J. Med. 7 (1914) 444-454
8. Eiberg H., Gardiner R.M., and Mohr J. Batten disease (Spielmeyer-Sjogren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16. Clin. Genet. 36 (1989) 217-218
9. The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 82 (1995) 949-957
10. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., and Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376 (1995) 584-587
11. Sleat D.E., Donnelly R.J., Lackland H., Liu C.G., Sohar I., Pullarkat R.K., and Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277 (1997) 1802-1805
12. Savukoski M., Klockars T., Holmberg V., Santavuori P., Lander E.S., and Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat. Genet. 19 (1998) 286-288
13. Ranta S., Zhang Y., Ross B., Lonka L., Takkunen E., Messer A., Sharp J., Wheeler R., Kusumi K., Mole S., Liu W., Soares M.B., Bonaldo M.F., Hirvasniemi A., de la Chapelle A., Gilliam T.C., and Lehesjoki A.E. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat. Genet. 23 (1999) 233-236
14. Gao H., Boustany R.M., Espinola J.A., Cotman S.L., Srinidhi L., Antonellis K.A., Gillis T., Qin X., Liu S., Donahue L.R., Bronson R.T., Faust J.R., Stout D., Haines J.L., Lerner T.J., and MacDonald M.E. Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am. J. Hum. Genet. 70 (2002) 324-335
15. Wheeler R.B., Sharp J.D., Schultz R.A., Joslin J.M., Williams R.E., and Mole S.E. The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am. J. Hum. Genet. 70 (2002) 537-542
16. Siintola E., Partanen S., Strömme P., Haapanen A., Haltia M., Maehlen J., Lehesjoki A.E., and Tyynelä J. Cathepsin D deficiency underlies congenital human neuronal ceroidlipofuscinosis. Brain 129 (2006) 1438-1445
17. Steinfeld R., Reinhardt K., Schreiber K., Hillebrand M., Kraetzner R., Brück W., Saftig P., and Gärtner J. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am. J. Hum. Genet. 78 (2006) 988-998
18. Hirvasniemi A., Lang H., Lehesjoki A.E., and Leisti J. Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J. Med. Genet. 31 (1994) 177-182
19. Jarvela I., Schleutker J., Haataja L., Santavuori P., Puhakka L., Manninen T., Palotie A., Sandkuijl L.A., Renlund M., White R., Aula P., and Peltonen L. Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics 9 (1991) 170-173
20. Camp L.A., and Hofmann S.L. Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J. Biol. Chem. 268 (1993) 22566-22574
21. Hellsten E., Vesa J., Olkkonen V.M., Jalanko A., and Peltonen L. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J. 15 (1996) 5240-5245
22. Verkruyse L.A., and Hofmann S.L. Lysosomal targeting of palmitoyl-protein thioesterase. J. Biol. Chem. 271 (1996) 15831-15836
23. Heinonen O., Kyttala A., Lehmus E., Paunio T., Peltonen L., and Jalanko A. Expression of palmitoyl protein thioesterase in neurons. Mol. Genet. Metab. 69 (2000) 123-129
24. Lehtovirta M., Kyttala A., Eskelinen E.L., Hess M., Heinonen O., and Jalanko A. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum. Mol. Genet. 10 (2001) 69-75
25. Ahtiainen L., Van Diggelen O.P., Jalanko A., and Kopra O. Palmitoyl protein thioesterase 1 is targeted to the axons in neurons. J. Comp. Neurol. 455 (2003) 368-377
26. Korey C.A., and MacDonald M.E. An over-expression system for characterizing Ppt1 function in Drosophila. BMC Neurosci. 4 (2003) 30
27. Porter M.Y., Turmaine M., and Mole S.E. Identification and characterization of Caenorhabditis elegans palmitoyl protein thioesterase1. J. Neurosci. Res. 79 (2005) 836-848
28. Santavuori P., Haltia M., Rapola J., and Raitta C. Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J. Neurol. Sci. 18 (1973) 257-267
29. Santavuori P., Haltia M., and Rapola J. Infantile type of so-called neuronal ceroid-lipofuscinosis. Dev. Med. Child Neurol. 16 (1974) 644-653
30. Das A.K., Becerra C.H., Yi W., Lu J.Y., Siakotos A.N., Wisniewski K.E., and Hofmann S.L. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J. Clin. Invest. 102 (1998) 361-370
31. Mitchison H.M., Hofmann S.L., Becerra C.H., Munroe P.B., Lake B.D., Crow Y.J., Stephenson J.B., Williams R.E., Hofman I.L., Taschner P.E., Martin J.J., Philippart M., Andermann E., Andermann F., Mole S.E., Gardiner R.M., and O'Rawe A.M. Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum. Mol. Genet. 7 (1998) 291-297
32. van Diggelen O.P., Thobois S., Tilikete C., Zabot M.T., Keulemans J.L., van Bunderen P.A., Taschner P.E., Losekoot M., and Voznyi Y.V. Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann. Neurol. 50 (2001) 269-272
33. Haltia M., Rapola J., and Santavuori P. Infantile type of so-called neuronal ceroid-lipofuscinosis. Histological and electron microscopic studies. Acta Neuropathol. (Berl) 26 (1973) 157-170
34. Tyynela J., Palmer D.N., Baumann M., and Haltia M. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett. 330 (1993) 8-12
35. van Diggelen O.P., Keulemans J.L., Winchester B., Hofman I.L., Vanhanen S.L., Santavuori P., and Voznyi Y.V. A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL. Mol. Genet. Metab. 66 (1999) 240-244
36. Voznyi Y.V., Keulemans J.L., Mancini G.M., Catsman-Berrevoets C.E., Young E., Winchester B., Kleijer W.J., and van Diggelen O.P. A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J. Med. Genet. 36 (1999) 471-474
37. Kohan R., de Halac I.N., Tapia Anzolini V., Cismondi A., Oller Ramirez A.M., Paschini Capra A., and de Kremer R.D. Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses. Clin. Biochem. 38 (2005) 492-494
38. Bellizzi III J.J., Widom J., Kemp C., Lu J.Y., Das A.K., Hofmann S.L., and Clardy J. The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4573-4578
39. Mole S.E., Williams R.E., and Goebel H.H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6 (2005) 107-126
40. Sharp J.D., Wheeler R.B., Lake B.D., Savukoski M., Jarvela I.E., Peltonen L., Gardiner R.M., and Williams R.E. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum. Mol. Genet. 6 (1997) 591-595
41. Vines D.J., and Warburton M.J. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. FEBS Lett. 443 (1999) 131-135
42. Hall N.A., Lake B.D., Dewji N.N., and Patrick A.D. Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten's disease (ceroid-lipofuscinosis). Biochem. J. 275 Pt 1 (1991) 269-272
43. Palmer D.N., Fearnley I.M., Walker J.E., Hall N.A., Lake B.D., Wolfe L.S., Haltia M., Martinus R.D., and Jolly R.D. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am. J. Med. Genet. 42 (1992) 561-567
44. Ezaki J., Tanida I., Kanehagi N., and Kominami E. A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase. J. Neurochem. 72 (1999) 2573-2582
45. Williams R.E., Gottlob I., Lake B.D., Goebel H.H., Winchester B.G., and Wheeler R.B. CLN2 Classical late infantile NCL. In: Goebel H.H., Mole S.E., and Lake B.D. (Eds). The Neuronal Ceroid Lipofuscinosis (Batten Disease) (1999), IOS Press, Amsterdam 37-54
46. Hartikainen J.M., Ju W., Wisniewski K.E., Moroziewicz D.N., Kaczmarski A.L., McLendon L., Zhong D., Suarez C.T., Brown W.T., and Zhong N. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Mol. Genet. Metab. 67 (1999) 162-168
47. Sleat D.E., Gin R.M., Sohar I., Wisniewski K., Sklower-Brooks S., Pullarkat R.K., Palmer D.N., Lerner T.J., Boustany R.M., Uldall P., Siakotos A.N., Donnelly R.J., and Lobel P. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am. J. Hum. Genet. 64 (1999) 1511-1523
48. Steinfeld R., Heim P., von Gregory H., Meyer K., Ullrich K., Goebel H.H., and Kohlschutter A. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am. J. Med. Genet. 112 (2002) 347-354
49. Ju W., Zhong R., Moore S., Moroziewicz D., Currie J.R., Parfrey P., Brown W.T., and Zhong N. Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles. J. Med. Genet. 39 (2002) 822-825
50. Mitchison H.M., Taschner P.E., O'Rawe A.M., de Vos N., Phillips H.A., Thompson A.D., Kozman H.M., Haines J.L., Schlumpf K., D'Arigo K., Boustany R.M., Callen D.F., Breuning M.H., Gardiner R.M., Mole S.E., and Lerner T.J. Genetic mapping of the Batten disease locus (CLN3) to the interval D16S288-D16S383 by analysis of haplotypes and allelic association. Genomics 22 (1994) 465-468
51. Jarvela I., Sainio M., Rantamaki T., Olkkonen V.M., Carpen O., Peltonen L., and Jalanko A. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum. Mol. Genet. 7 (1998) 85-90
52. Jarvela I., Lehtovirta M., Tikkanen R., Kyttala A., and Jalanko A. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum. Mol. Genet. 8 (1999) 1091-1098
53. Luiro K., Kopra O., Lehtovirta M., and Jalanko A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum. Mol. Genet. 10 (2001) 2123-2131
54. Mitchison H.M., Munroe P.B., O'Rawe A.M., Taschner P.E., de Vos N., Kremmidiotis G., Lensink I., Munk A.C., D'Arigo K.L., Anderson J.W., Lerner T.J., Moyzis R.K., Callen D.F., Breuning M.H., Doggett N.A., Gardiner R.M., and Mole S.E. Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3. Genomics 40 (1997) 346-350
55. Taschner P.E., de Vos N., and Breuning M.H. Cross-species homology of the CLN3 gene. Neuropediatrics 28 (1997) 18-20
56. Mitchell W.A., Porter M., Kuwabara P., and Mole S.E. Genomic structure of three CLN3-like genes in Caenorhabditis elegans. Eur. J. Paediatr. Neurol. 5 (2001) 121-125 (Suppl A)
57. Gachet Y., Codlin S., Hyams J.S., and Mole S.E. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis. J. Cell Sci. 118 (2005) 5525-5536
58. Hofman I., Kohlschutter A., Santavuori P., Gottlob I., Goebel H.H., Lake B.D., Schutgens R.B.H., Greene N.D.E., Leung K.-Y., Mitchison H.M., Munroe P.B., and Taschner P.E.M. CLN3 Juvenile NCL. In: Goebel H.H., Mole S.E., and Lake B.D. (Eds). The Neuronal Ceroid Lipofuscinosis (Batten Disease) (1999), IOS Press, Amsterdam 55-76
59. Savukoski M., Kestila M., Williams R., Jarvela I., Sharp J., Harris J., Santavuori P., Gardiner M., and Peltonen L. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am. J. Hum. Genet. 55 (1994) 695-701
60. Isosomppi J., Vesa J., Jalanko A., and Peltonen L. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum. Mol. Genet. 11 (2002) 885-891
61. Vesa J., Chin M.H., Oelgeschlager K., Isosomppi J., DellAngelica E.C., Jalanko A., and Peltonen L. Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol. Biol. Cell 13 (2002) 2410-2420
62. Santavuori P., Rapola J., Sainio K., and Raitta C. A variant of Jansky-Bielschowsky disease. Neuropediatrics 13 (1982) 135-141
63. Pineda-Trujillo N., Cornejo W., Carrizosa J., Wheeler R.B., Munera S., Valencia A., Agudelo-Arango J., Cogollo A., Anderson G., Bedoya G., Mole S.E., and Ruiz-Linares A. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. Neurology 64 (2005) 740-742
64. Melville S.A., Wilson C.L., Chiang C.S., Studdert V.P., Lingaas F., and Wilton A.N. A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs. Genomics 86 (2005) 287-294
65. Heine C., Koch B., Storch S., Kohlschutter A., Palmer D.N., and Braulke T. Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J. Biol. Chem. 279 (2004) 22347-22352
66. Mole S.E., Michaux G., Codlin S., Wheeler R.B., Sharp J.D., and Cutler D.F. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp. Cell Res. 298 (2004) 399-406
67. Williams R.E., Lake B.D., Elleder M., and Sharp J.D. CLN6 Variant late infantile/early juvenile NCL. In: Goebel H.H., Mole S.E., and Lake B.D. (Eds). The Neuronal Ceroid Lipofuscinosis (Batten Disease) (1999), IOS Press, Amsterdam 102-113
68. Sharp J.D., Wheeler R.B., Parker K.A., Gardiner R.M., Williams R.E., and Mole S.E. Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis. Human Mutat. 22 (2003) 35-42
69. Teixeira C.A., Espinola J., Huo L., Kohlschutter J., Persaud Sawin D.A., Minassian B., Bessa C.J., Guimaraes A., Stephan D.A., Sa Miranda M.C., MacDonald M.E., Ribeiro M.G., and Boustany R.M. Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis. Human Mutat. 21 (2003) 502-508
70. Siintola E., Topcu M., Kohlschutter A., Salonen T., Joensuu T., Anttonen A.K., and Lehesjoki A.E. Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin. Clin. Genet. 68 (2005) 167-173
71. Broom M.F., and Zhou C. Fine mapping of ovine ceroid lipofuscinosis confirms orthology with CLN6. Eur. J. Paediatr. Neurol. 5 Suppl (2001) 33-35
72. Tammen I., Cook R.W., Nicholas F.W., and Raadsma H.W. Neuronal ceroid lipofuscinosis in Australian Merino sheep: a new animal model. Eur. J. Paediatr. Neurol. 5 (2001) 37-41 (Suppl A)
73. Tahvanainen E., Ranta S., Hirvasniemi A., Karila E., Leisti J., Sistonen P., Weissenbach J., Lehesjoki A.E., and de la Chapelle A. The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7267-7270
74. Lonka L., Kyttala A., Ranta S., Jalanko A., and Lehesjoki A.E. The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum. Mol. Genet. 9 (2000) 1691-1697
75. Lonka L., Salonen T., Siintola E., Kopra O., Lehesjoki A.E., and Jalanko A. Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells. J. Neurosci. Res. 76 (2004) 862-871
76. Winter E., and Ponting C.P. TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?. Trends Biochem. Sci. 27 (2002) 381-383
77. Herva R., Tyynela J., Hirvasniemi A., Syrjakallio-Ylitalo M., and Haltia M. Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis. Brain Pathol. 10 (2000) 215-222
78. Ranta S., Topcu M., Tegelberg S., Tan H., Ustubutun A., Saatci I., Dufke A., Enders H., Pohl K., Alembik Y., Mitchell W.A., Mole S.E., and Lehesjoki A.E. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Human Mutat. 23 (2004) 300-305
79. Cannelli N., Cassandrini D., Bertini E., Striano P., Fusco L., Gaggero R., Specchio N., Biancheri R., Vigevano F., Bruno C., Simonati A., Zara F., and Santorelli F.M. Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: another genetic hit in the Mediterranean. Neurogenetics 7 (2006) 111-117
80. Katz M.L., Khan S., Awano T., Shahid S.A., Siakotos A.N., and Johnson G.S. A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis. Biochem. Biophys. Res. Commun. 327 (2005) 541-547
81. Tyynelä J., Sohar I., Sleat D.E., Gin R.M., Donnelly R.J., Baumann M., Haltia M., and Lobel P. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 19 (2000) 2786-2792
82. Awano T., Katz M.L., O'Brien P., Taylor J.F., Evans J., Khan S., Sohar I., Lobel P., and Johnson G.S. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. Mol. Genet. Metab. 87 (2006) 341-348
83. Press E.M., Porter R.R., and Cebra J. The isolation and properties of a proteolytic enzyme, cathepsin D, from bovine spleen. Biochem. J. 74 (1960) 501-514
84. Rawlings N.D., and Barrett A.J. Families of aspartic peptidases, and those of unknown catalytic mechanism. Methods Enzymol. 248 (1995) 105-120
85. Myllykangas L., Tyynela J., Page-McCaw A., Rubin G.M., Haltia M.J., and Feany M.B. Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses. Neurobiol. Dis. 19 (2005) 194-199
86. Kohlschutter A., and Lake B.D. NCL variants without genetic assignment. In: Goebel H.H., Mole S.E., and Lake B.D. (Eds). The Neuronal Ceroid Lipofuscinosis (Batten Disease) (1999), IOS Press, Amsterdam 125-127
87. Stobrawa S.M., Breiderhoff T., Takamori S., Engel D., Schweizer M., Zdebik A.A., Bosl M.R., Ruether K., Jahn H., Draguhn A., Jahn R., and Jentsch T.J. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29 (2001) 185-196
88. Yoshikawa M., Uchida S., Ezaki J., Rai T., Hayama A., Kobayashi K., Kida Y., Noda M., Koike M., Uchiyama Y., Marumo F., Kominami E., and Sasaki S. CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes Cells 7 (2002) 597-605
89. Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., Schmitt A., Poet M., Steinfeld R., Schweizer M., Kornak U., and Jentsch T.J. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24 (2005) 1079-1091
90. Tang C.H., Lee J.W., Galvez M.G., Robillard L., Mole S.E., and Chapman H.A. Murine cathepsin f deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol. Cell. Biol. 26 (2006) 2309-2316
91. Berkovic S.F., Carpenter S., Andermann F., Andermann E., and Wolfe L.S. Kufs' disease: a critical reappraisal. Brain 111 Pt 1 (1988) 27-62
92. Martin J.J., Gottlob I., Goebel H.H., and Mole S.E. CLN4 Adult NCL. In: Goebel H.H., Mole S.E., and Lake B.D. (Eds). The Neuronal Ceroid Lipofuscinosis (Batten Disease) (1999), IOS Press, Amsterdam 77-90
93. Wheeler R.B., Sharp J.D., Mitchell W.A., Bate S.L., Williams R.E., Lake B.D., and Gardiner R.M. A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7. Mol. Genet. Metab. 66 (1999) 337-338
94. Williams R.E., Topcu M., Lake B.D., Mitchell W., and Mole S.E. CLN7 Turkish variant late infantile NCL. In: Goebel H.H., Mole S.E., and Lake B.D. (Eds). The Neuronal Ceroid Lipofuscinosis (Batten Disease) (1999), IOS Press, Amsterdam 114-116
95. Topcu M., Tan H., Yalnizoglu D., Usubutun A., Saatci I., Aynaci M., Anlar B., Topaloglu H., Turanli G., Kose G., and Aysun S. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk. J. Pediatr. 46 (2004) 1-10
96. Schulz A., Dhar S., Rylova S., Dbaibo G., Alroy J., Hagel C., Artacho I., Kohlschutter A., Lin S., and Boustany R.M. Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann. Neurol. 56 (2004) 342-350
97. Schulz A., Mousallem T., Venkataramani M., Persaud-Sawin D.A., Zucker A., Luberto C., Bielawska A., Bielawski J., Holthuis J.C., Jazwinski S.M., Kozhaya L., Dbaibo G.S., and Boustany R.M. The CLN9 protein, a regulator of dihydroceramide synthase. J. Biol. Chem. 281 (2006) 2784-2794